BLI Banque de Luxembourg Investments acquired a new position in Danaher Co. (NYSE:DHR - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 140,840 shares of the conglomerate's stock, valued at approximately $32,354,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in DHR. Kentucky Retirement Systems Insurance Trust Fund lifted its position in Danaher by 11.6% in the fourth quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate's stock valued at $4,874,000 after buying an additional 2,202 shares during the last quarter. FAS Wealth Partners Inc. increased its holdings in Danaher by 20.6% in the 4th quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock valued at $2,203,000 after purchasing an additional 1,639 shares during the last quarter. ORG Partners LLC lifted its stake in Danaher by 1,212.8% during the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate's stock worth $636,000 after purchasing an additional 2,559 shares in the last quarter. Generate Investment Management Ltd acquired a new stake in shares of Danaher in the fourth quarter valued at $8,044,000. Finally, Compass Capital Management Inc. raised its holdings in shares of Danaher by 4.8% in the 4th quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate's stock valued at $54,615,000 after buying an additional 10,994 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.
Insider Buying and Selling
In other news, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the sale, the executive vice president now owns 15,179 shares of the company's stock, valued at approximately $3,005,442. The trade was a 51.01 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 11.10% of the company's stock.
Wall Street Analyst Weigh In
A number of brokerages have issued reports on DHR. Stifel Nicolaus upgraded shares of Danaher from a "hold" rating to a "buy" rating and set a $260.00 price target on the stock in a research note on Friday, March 14th. Robert W. Baird reduced their target price on shares of Danaher from $231.00 to $225.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Citigroup restated a "buy" rating on shares of Danaher in a research note on Monday, April 7th. Royal Bank of Canada reiterated an "outperform" rating and issued a $250.00 price objective on shares of Danaher in a research note on Wednesday, April 23rd. Finally, Barclays boosted their target price on Danaher from $205.00 to $215.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 22nd. Five investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $264.40.
Read Our Latest Report on DHR
Danaher Price Performance
Shares of NYSE:DHR traded down $3.72 on Friday, hitting $191.10. The company had a trading volume of 2,538,165 shares, compared to its average volume of 4,389,016. The company has a market cap of $136.76 billion, a PE ratio of 36.19, a PEG ratio of 2.66 and a beta of 0.80. The business has a 50 day moving average of $198.72 and a 200 day moving average of $219.95. Danaher Co. has a 52-week low of $171.00 and a 52-week high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.
Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. The company had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. As a group, equities analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.
Danaher Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.67%. Danaher's payout ratio is 24.85%.
Danaher Company Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More

Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.